Article
Ribavirin upregulates interleukin-12 receptor and induces T cell differentiation towards type 1 in chronic hepatitis C.
Journal of gastroenterology and hepatology - 1 May 2004
Shiina Masaaki, Kobayashi Koju, Satoh Hiroko, Niitsuma Hirofumi, Ueno Yoshiyuki, Shimosegawa Tooru
Abstract excerpt
BACKGROUND AND AIM: The mechanisms of ribavirin as an immune modulator have not been fully revealed, contrary to its clinical benefit in chronic hepatitis C. Recently, host immune defense, especially cytotoxic T lymphocytes and T helper cells, have been considered to be closely related to the pathophysiology of chronic viral hepatitis. The aim of the present study was to evaluate the function of ribavirin in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
